Search Results - Mark Sculpher
- Showing 1 - 19 results of 19
-
1
Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates. by Sakshi Mohan, Paul Revill, Stefano Malvolti, Melissa Malhame, Mark Sculpher, Paul M Kaye
Published in PLoS Neglected Tropical Diseases (2022-06-01)Get full text
Article -
2
Health-related quality of life implications of plantar ulcers resulting from neuropathic damage caused by leprosy: An analysis from the trial of autologous blood products (TABLE tr... by Naomi Kate Gibbs, Jessica Ochalek, Indra Bahadur Napit, Dilip Shrestha, Pedro Saramago Goncalves, Richard J Lilford, Mark Sculpher
Published in PLoS ONE (2025-01-01)Get full text
Article -
3
Methodological issues in economic evaluations of emergency transport systems in low-income and middle-income countries by Dmitri Nepogodiev, Richard Lilford, Samuel I Watson, Alan J Girling, Peter Diggle, Peter J Chilton, Mark Sculpher, Darius Erlangga
Published in BMJ Global Health (2021-03-01)Get full text
Article -
4
The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management... by Nicholas I Paton, Wolfgang Stöhr, Lars Oddershede, Alejandro Arenas-Pinto, Simon Walker, Mark Sculpher, David T Dunn, on behalf of the PIVOT trial team
Published in Health Technology Assessment (2016-03-01)Get full text
Article -
5
Development of the natural history component of an early economic model for primary sclerosing cholangitis by Christopher Bowlus, Cynthia Levy, Kris V. Kowdley, Nandita Kachru, Sushanth Jeyakumar, Yael Rodriguez-Guadarrama, Nathaniel Smith, Andrew Briggs, Mark Sculpher, Daniel Ollendorf
Published in Orphanet Journal of Rare Diseases (2025-03-01)Get full text
Article -
6
Cost-Effectiveness of Introducing Nuvaxovid to COVID-19 Vaccination in the United Kingdom: A Dynamic Transmission Model by Clive Pritchard, Lucie Kutikova, Richard Pitman, Kira Zhi Hua Lai, Hadi Beyhaghi, IIana Gibbons, Amanda Erbe, Marija Živković-Gojović, Catherine Cosgrove, Mark Sculpher, David Salisbury
Published in Vaccines (2025-02-01)Get full text
Article -
7
Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee. by Beth Woods, Andrea Manca, Helen Weatherly, Pedro Saramago, Eleftherios Sideris, Christina Giannopoulou, Stephen Rice, Mark Corbett, Andrew Vickers, Matthew Bowes, Hugh MacPherson, Mark Sculpher
Published in PLoS ONE (2017-01-01)Get full text
Article -
8
Cost-effectiveness analysis of acupuncture, counselling and usual care in treating patients with depression: the results of the ACUDep trial. by Eldon Spackman, Stewart Richmond, Mark Sculpher, Martin Bland, Stephen Brealey, Rhian Gabe, Ann Hopton, Ada Keding, Harriet Lansdown, Sara Perren, David Torgerson, Ian Watt, Hugh MacPherson
Published in PLoS ONE (2014-01-01)Get full text
Article -
9
Acupuncture and counselling for depression in primary care: a randomised controlled trial. by Hugh MacPherson, Stewart Richmond, Martin Bland, Stephen Brealey, Rhian Gabe, Ann Hopton, Ada Keding, Harriet Lansdown, Sara Perren, Mark Sculpher, Eldon Spackman, David Torgerson, Ian Watt
Published in PLoS Medicine (2013-01-01)Get full text
Article -
10
Developing a Modeling Framework for Quantifying the Health and Cost Implications of Antibiotic Resistance for Surgical Procedures by Heather Davies, Joel Russell, Angel Varghese, Hayden Holmes, Marta O. Soares, Beth Woods, Ruth Puig-Peiro, Stephanie Evans, Rory Tierney, Stuart Mealing, Mark Sculpher, Julie V. Robotham
Published in MDM Policy & Practice (2023-02-01)Get full text
Article -
11
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model by Beth Woods, Laetitia Schmitt, Dina Jankovic, Benjamin Kearns, Alison Scope, Shijie Ren, Tushar Srivastava, Chu Chang Ku, Jean Hamilton, Claire Rothery, Laura Bojke, Mark Sculpher, Sue Harnan
Published in Health Technology Assessment (2024-06-01)Get full text
Article -
12
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model by Sue Harnan, Ben Kearns, Alison Scope, Laetitia Schmitt, Dina Jankovic, Jean Hamilton, Tushar Srivastava, Harry Hill, Chu Chang Ku, Shijie Ren, Claire Rothery, Laura Bojke, Mark Sculpher, Beth Woods
Published in Health Technology Assessment (2024-10-01)Get full text
Article -
13
The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation by Diane Farrar, Mark Simmonds, Susan Griffin, Ana Duarte, Debbie A Lawlor, Mark Sculpher, Lesley Fairley, Su Golder, Derek Tuffnell, Martin Bland, Fidelma Dunne, Donald Whitelaw, John Wright, Trevor A Sheldon
Published in Health Technology Assessment (2016-11-01)Get full text
Article -
14
Acupuncture for chronic pain and depression in primary care: a programme of research by Hugh MacPherson, Andrew Vickers, Martin Bland, David Torgerson, Mark Corbett, Eldon Spackman, Pedro Saramago, Beth Woods, Helen Weatherly, Mark Sculpher, Andrea Manca, Stewart Richmond, Ann Hopton, Janet Eldred, Ian Watt
Published in Programme Grants for Applied Research (2017-01-01)Get full text
Article -
15
A qualitative study on the feasibility and acceptability of institutionalizing health technology assessment in Malawi by Joseph Mfutso-Bengo, Faless Jeremiah, Florence Kasende-Chinguwo, Wingston Ng’ambi, Nthanda Nkungula, Isabel Kazanga-Chiumia, Mercy Juma, Marlen Chawani, Jobiba Chinkhumba, Pakwanja Twea, Emily Chirwa, Kate Langwe, Gerald Manthalu, Lucky Gift Ngwira, Dominic Nkhoma, Tim Colbourn, Paul Revill, Mark Sculpher
Published in BMC Health Services Research (2023-04-01)Get full text
Article -
16
Randomised trial of stable chest pain investigation: 3-year clinical and quality of life results from CE-MARC 2 by Colin Berry, Simon Walker, Chiara Bucciarelli-Ducci, Sven Plein, Abhiram Prasad, Kenneth Mangion, Petra Bijsterveld, Catherine Reynolds, Catherine Fernandez, Julia Brown, Erica Dall’Armellina, Deborah Stocken, Mark Sculpher, Colin C. Everett, Gerry P. McCann, James R. Foley, John P. Greenwood
Published in Open Heart (2023-05-01)Get full text
Article -
17
Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With HIV by Vilija R. Joyce MS, Huiying Sun PhD, Paul G. Barnett PhD, Nick Bansback PhD, Susan C. Griffin MSc, Ahmed M. Bayoumi MD, Aslam H. Anis PhD, Mark Sculpher PhD, William Cameron MD, Sheldon T. Brown MD, Mark Holodniy MD, Douglas K. Owens MD, MS
Published in MDM Policy & Practice (2017-07-01)Get full text
Article -
18
Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care... by Richard D Neal, Kevin Franks, David Torgerson, Rachael L Murray, David R Baldwin, Michael Darby, Henrik Moller, Richard Booton, Una MacLeod, Sam M Janes, Samantha L Quaife, Sebastian Hinde, Matthew EJ Callister, Suzanne Rogerson, Rhian Gabe, Mark Sculpher, Philip AJ Crosbie, Irene Simmonds, Martyn Kennedy, Nazia Ahmed, Ann Cochrane, Mike Messenger, Puvanendran Tharmanathan
Published in BMJ Open (2020-09-01)Get full text
Article -
19
Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study by Louise Clare Brown, Hashim U Ahmed, Rita Faria, Ahmed El-Shater Bosaily, Rhian Gabe, Richard S Kaplan, Mahesh Parmar, Yolanda Collaco-Moraes, Katie Ward, Richard Graham Hindley, Alex Freeman, Alexander Kirkham, Robert Oldroyd, Chris Parker, Simon Bott, Nick Burns-Cox, Tim Dudderidge, Maneesh Ghei, Alastair Henderson, Rajendra Persad, Derek J Rosario, Iqbal Shergill, Mathias Winkler, Marta Soares, Eldon Spackman, Mark Sculpher, Mark Emberton
Published in Health Technology Assessment (2018-07-01)Get full text
Article
